184 related articles for article (PubMed ID: 31918715)
1. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.
N'Guessan KF; Patel PH; Qi X
Cell Commun Signal; 2020 Jan; 18(1):6. PubMed ID: 31918715
[TBL] [Abstract][Full Text] [Related]
2. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
Chu Z; Abu-Baker S; Palascak MB; Ahmad SA; Franco RS; Qi X
PLoS One; 2013; 8(10):e75507. PubMed ID: 24124494
[TBL] [Abstract][Full Text] [Related]
3. Detection of cancer cells using SapC-DOPS nanovesicles.
Davis HW; Hussain N; Qi X
Mol Cancer; 2016 May; 15(1):33. PubMed ID: 27160923
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors.
Blanco VM; Chu Z; Vallabhapurapu SD; Sulaiman MK; Kendler A; Rixe O; Warnick RE; Franco RS; Qi X
Oncotarget; 2014 Aug; 5(16):7105-18. PubMed ID: 25051370
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.
Wojton J; Chu Z; Mathsyaraja H; Meisen WH; Denton N; Kwon CH; Chow LM; Palascak M; Franco R; Bourdeau T; Thornton S; Ostrowski MC; Kaur B; Qi X
Mol Ther; 2013 Aug; 21(8):1517-25. PubMed ID: 23732993
[TBL] [Abstract][Full Text] [Related]
6. SapC-DOPS nanovesicles as targeted therapy for lung cancer.
Zhao S; Chu Z; Blanco VM; Nie Y; Hou Y; Qi X
Mol Cancer Ther; 2015 Feb; 14(2):491-8. PubMed ID: 25670331
[TBL] [Abstract][Full Text] [Related]
7. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.
N'Guessan KF; Davis HW; Chu Z; Vallabhapurapu SD; Lewis CS; Franco RS; Olowokure O; Ahmad SA; Yeh JJ; Bogdanov VY; Qi X
Mol Ther; 2020 Aug; 28(8):1876-1886. PubMed ID: 32516572
[TBL] [Abstract][Full Text] [Related]
9. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
Davis HW; Vallabhapurapu SD; Chu Z; Wyder MA; Greis KD; Fannin V; Sun Y; Desai PB; Pak KY; Gray BD; Qi X
Cells; 2020 Aug; 9(9):. PubMed ID: 32854321
[TBL] [Abstract][Full Text] [Related]
10. Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.
Davis HW; Vallabhapurapu SD; Chu Z; Vallabhapurapu SL; Franco RS; Mierzwa M; Kassing W; Barrett WL; Qi X
Oncotarget; 2019 Jan; 10(8):856-868. PubMed ID: 30783515
[TBL] [Abstract][Full Text] [Related]
11. Saposin C coupled lipid nanovesicles specifically target arthritic mouse joints for optical imaging of disease severity.
Qi X; Flick MJ; Frederick M; Chu Z; Mason R; DeLay M; Thornton S
PLoS One; 2012; 7(3):e33966. PubMed ID: 22470501
[TBL] [Abstract][Full Text] [Related]
12. Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
Sun Y; Liou B; Chu Z; Fannin V; Blackwood R; Peng Y; Grabowski GA; Davis HW; Qi X
EBioMedicine; 2020 May; 55():102735. PubMed ID: 32279952
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylserine: A cancer cell targeting biomarker.
Sharma B; Kanwar SS
Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
[TBL] [Abstract][Full Text] [Related]
14. Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.
Winter PM; Pearce J; Chu Z; McPherson CM; Takigiku R; Lee JH; Qi X
J Magn Reson Imaging; 2015 Apr; 41(4):1079-87. PubMed ID: 24797437
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer: current standards, working towards a new therapeutic approach.
Olowokure O; Qi X
Expert Rev Anticancer Ther; 2014 May; 14(5):495-7. PubMed ID: 24621210
[TBL] [Abstract][Full Text] [Related]
16. Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
Davis HW; Kaynak A; Vallabhapurapu SD; Qi X
World J Gastrointest Oncol; 2021 Jun; 13(6):550-559. PubMed ID: 34163572
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles.
Abu-Baker S; Chu Z; Stevens AM; Li J; Qi X
J Cancer Ther; 2012 Aug; 3(4):321-326. PubMed ID: 25485166
[TBL] [Abstract][Full Text] [Related]
18. SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents.
Kaynak A; Davis HW; Vallabhapurapu SD; Pak KY; Gray BD; Qi X
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832975
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
